← Browse by Condition
Medical Condition

brain tumor adult

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for brain tumor adult sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain tumor adult Clinical Trials

How many clinical trials are currently recruiting for brain tumor adult?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for brain tumor adult, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for brain tumor adult?
brain tumor adult research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a brain tumor adult clinical trial?
Eligibility criteria for brain tumor adult trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
University of Texas Southwestern Medical Center 1 trial
University of Michigan 1 trial
University Hospital, Brest 1 trial
Region Skane 1 trial

Recruiting Clinical Trials

NCT03067467
Recruiting
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
Enrollment
25 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT07225101 Phase 4
Recruiting
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
Enrollment
160 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT06962215
Recruiting
The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)
Enrollment
250 pts
Location
France
Sponsor
University Hospital, Brest
View Trial →
NCT06922500
Recruiting
Processed EEG for Monitoring of Anesthetic Depth in Intracranial Tumor Surgery
Enrollment
126 pts
Location
Sweden
Sponsor
Region Skane
View Trial →

Related Conditions

wound closure (1) spine (1) neurovascular (1) hemorrhagic stroke intracerebral (1) traumatic brain injury (1) processed eeg (1) total intravenous anesthesia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology